[1] 聂丹,刘玲,夏纪毅,等. 血管生成素样蛋白4(ANGPTL4)敲低抑制宫颈癌SiHa细胞增殖并促进其凋亡[J]. 细胞与分子免疫学杂志,2016,32(4):488
[2] 吴欣,黄健,刘畅,等. 1,25-二羟维生素D3对2型糖尿病肾病患者血管生成素样蛋白4水平的影响[J]. 实用医学杂志,2017, 33(13):2201
[3] 徐龙鑫,刘镜,张麟,等. 关岭黄牛ANGPTL4基因多态性与生长性状关联分析[J]. 江苏农业科学,2016,44(9):51
[4] 孙瑶,吕红彬,周琦,等. 血管生成素样蛋白4(ANGPTL4)在增生型糖尿病视网膜病变患者血清和玻璃体中的表达[J]. 眼科新进展,2017,37(1):49
[5] 李文浩,刘秀,李少斌,等. 藏绵羊ANGPTL4基因第3内含子、第6外显子多态性分析[J]. 江西农业大学学报,2017,39(3):443
[6] Kubo H,Kitajima Y,Kai K,et al. Regulation and clinical significance of the hypoxia-induced expression of ANGPTL4 in gastric cancer[J]. Oncol Letters,2016,11(2):1026
[7] 陈凌燕,尹卫东,唐朝克. LPL和Angptl4在糖尿病性心脏病发生发展中作用的研究新进展[J]. 生理科学进展,2017,19(5):328
[8] Zhu X,Guo X,Wu S,et al. ANGPTL4 correlates with NSCLC progression and regulates epithelial-mesenchymal transition via ERK pathway[J]. Lung,2016,194(4):637
[9] 陈重九,范思邈,郑瑞茂. 血管生成素样蛋白-4在动脉粥样硬化过程中的双重作用[J]. 生理科学进展,2016,17(5):380
[10] Ren Z. The ANGPTL3-4-8 model,a molecular mechanism for triglyceride trafficking[J]. Open Biology,2016,6(4):150272
[11] 刘秀婵,白人骁. ANGPTL3与ANGPTL4在类风湿关节炎患者血清中的表达意义[J]. 中国实验诊断学,2016,20(10):1740
[12] Abid K,Trimeche T,Mili D,et al. ANGPTL4 variants E40K and T266M are associated with lower fasting triglyceride levels and predicts cardiovascular disease risk in Type 2 diabetic Tunisian population[J]. Lip Health Dis,2016,15(1):63
[13] Dong D,Jia L,Zhou Y,et al. Serum level of ANGPTL4 as a potential biomarker in renal cell carcinoma[J]. UrolOncol,2017,35(5):279
[14] Gomez P E,Liabotis-Fontugne A,Durand M,et al. ANGPTL4-79.tential biomarkere risk in Type 2 diabetic Tunisian population[J]. Lip Health Dis,2016,15(1):63
[15] 王立娟,刘晨,许元文. ANGPTL4对苯肾上腺素诱导的心肌纤维化的调控[J]. 实用医学杂志,2017,33(12):1939
[16] 吴翠霞,张艳红,葛小花,等. 高危型HPV感染与宫颈癌前病变与宫颈癌的相关性研究[J]. 中华医院感染学杂志,2016,26(11):2568
[17] 彭俊,黄勇. 90例年轻宫颈癌患者临床特征及术后复发和预后相关因素分析[J]. 实用妇产科杂志,2016,32(1):42
[18] 李双,李雄,张媛,等. 宫颈癌的手术-病理分期和评分系统的建立和验证[J]. 现代妇产科进展,2016,25(11):801
[19] 宋亮,谢思遐,战军,等. 652例早期宫颈癌患者临床病理特征分析及选择低危患者条件探讨[J]. 实用妇产科杂志,2016,32(2):126
[20] 陈晓露,张波,吴蓉宜. CK26、VEGF和p53蛋白表达对宫颈癌患者预后的预测价值研究[J]. 重庆医学,2016,45(8):1083
[1]李晶晶,赵卫东,王德华.72例宫颈癌术后并发症及卵巢功能分析[J].天津医科大学学报,2014,20(01):63.
[2]崔丽阳,岳天孚.高危型HPV持续感染的影响因素探讨[J].天津医科大学学报,2014,20(03):209.
CUI Li-yang,YUE Tian-fu.Investigation on factors for persistent high-risk human papilloma virus infection[J].Journal of Tianjin Medical University,2014,20(05):209.
[3]孙 艳,齐 政,王德华,等.miR-186通过靶定CEA抑制宫颈癌细胞转移[J].天津医科大学学报,2016,22(04):288.
SUN Yan,QI Zheng,WANG De-hua,et al.miR-186 inhibits cervical cancer migration by targetting CEA[J].Journal of Tianjin Medical University,2016,22(05):288.
[4]李 娜,李洪林,尹利荣.HPV E6/E7 mRNA与YAP在宫颈癌中的表达与相关性研究[J].天津医科大学学报,2018,24(04):307.
LI Na,LI Hong-lin,YIN Li-rong.HPV E6/E7 mRNA and YAP expression and their correlation in cervical carcinoma[J].Journal of Tianjin Medical University,2018,24(05):307.
[5]曲首辉,鲍志敏,刘荣欣.TCT、活检病理在宫颈上皮瘤变及早期宫颈癌诊断中的价值分析[J].天津医科大学学报,2018,24(04):360.
[6]闫晓芳,谢 虹,汤 华.miR-3685通过靶向CTTN抑制宫颈癌细胞的迁移、侵袭及生长[J].天津医科大学学报,2020,26(01):8.
YAN Xiao-fang,XIE Hong,TANG Hua.miR-3685 inhibits migration, invasion and growth of cervical cancer cells by targeting CTTN[J].Journal of Tianjin Medical University,2020,26(05):8.
[7]白丽丽,汤华.TNF-α诱导的circMAN1A2促进宫颈癌细胞的迁移、侵袭和增殖[J].天津医科大学学报,2020,26(02):103.
BAI Li-li,TANG Hua.TNF-α-induced circMAN1A2 promotes migration, invasion and proliferation of cervical cancer cells[J].Journal of Tianjin Medical University,2020,26(05):103.
[8]赵敬,杨金豪,张文帆,等.2009—2020年中国女性生殖道支原体、衣原体和人乳头瘤病毒感染与宫颈癌发生相关性的Meta分析[J].天津医科大学学报,2021,27(04):396.
ZHAO Jing,YANG Jin-hao,ZHANG Wen-fan,et al.A meta-analysis of association between Mycoplasma,Chlamydia infection and Human papillomavirus infection in female genital tract and cervical cancer in China from 2009 to 2020[J].Journal of Tianjin Medical University,2021,27(05):396.
[9]赵敬,杨金豪 综述,常艳敏,等.中国宫颈癌DNA甲基化标志物的研究进展[J].天津医科大学学报,2021,27(05):545.
[10]李广宁 综述,曹文枫 审校.女性生殖系统双原发癌的研究进展[J].天津医科大学学报,2021,27(06):655.